Literature DB >> 11050367

Capsaicin evoked pain and allodynia in post-herpetic neuralgia.

Karin L Petersen1, Howard L Fields, Jannick Brennum, Paola Sandroni, Michael C Rowbotham.   

Abstract

The hypothesis that the pain and allodynia associated with post-herpetic neuralgia (PHN) is maintained by a combination of input from preserved primary afferent nociceptors and sensitization of central pain transmitting neurons was examined in 17 subjects with PHN. Pain, allodynia, thermal sensory function, cutaneous innervation, and response to controlled application of 0.075% capsaicin were measured. Compared to mirror-image skin, applying capsaicin on a 9 cm(2) area of PHN skin significantly increased overall PHN pain and allodynia in 11 of 17 subjects. These 'capsaicin responders' were characterized by higher average daily pain, higher allodynia ratings, and relatively preserved sensory function at baseline compared to the non-responders. In three of the 'capsaicin responders' the area of allodynia expanded into previously non-allodynic and non-painful skin that had normal sensory function and cutaneous innervation. These observations support the hypothesis that allodynia in some PHN patients is a form of chronic secondary hyperalgesia maintained by input from intact and possibly 'irritable' primary afferent nociceptors to a sensitized CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050367     DOI: 10.1016/S0304-3959(00)00311-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  26 in total

1.  Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy.

Authors:  Claudia M Campbell; Mark S Kipnes; Bruce C Stouch; Kerrie L Brady; Margaret Kelly; William K Schmidt; Karin L Petersen; Michael C Rowbotham; James N Campbell
Journal:  Pain       Date:  2012-06-08       Impact factor: 6.961

2.  [Types of topical treatment for peripheral neuropathic pain : Mechanism of action and indications].

Authors:  R Baron; F Mahn
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

3.  Descending facilitation maintains long-term spontaneous neuropathic pain.

Authors:  Ruizhong Wang; Tamara King; Milena De Felice; Wenhong Guo; Michael H Ossipov; Frank Porreca
Journal:  J Pain       Date:  2013-04-19       Impact factor: 5.820

4.  Controlling neuropathic pain in HIV.

Authors:  Susama Verma; Lydia Estanislao; Letty Mintz; David Simpson
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

5.  Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.

Authors:  Lynn R Webster; Marvin Tark; Richard Rauck; Jeffrey K Tobias; Geertrui F Vanhove
Journal:  BMC Neurol       Date:  2010-10-11       Impact factor: 2.474

6.  Relief of post-herpetic neuralgia by surgical removal of painful skin: 5 years later.

Authors:  Karin Lottrup Petersen; Michael C Rowbotham
Journal:  Pain       Date:  2007-04-23       Impact factor: 6.961

Review 7.  Postherpetic neuralgia: from preclinical models to the clinic.

Authors:  Ada Delaney; Lesley A Colvin; Marie T Fallon; Robert G Dalziel; Rory Mitchell; Susan M Fleetwood-Walker
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

8.  Evaluation of symptom heterogeneity in neuropathic pain using assessments of sensory functions.

Authors:  Kathrin Arning; Ralf Baron
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Controlling Neuropathic Pain in HIV.

Authors:  Susama Verma; Lydia Estanislao; Letty Mintz; David Simpson
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

Review 10.  Translating nociceptive processing into human pain models.

Authors:  Martin Schmelz
Journal:  Exp Brain Res       Date:  2009-04-29       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.